PROLACTIN IN CHILDHOOD OBSESSIVE-COMPULSIVE DISORDER - CLINICAL CORRELATES AND RESPONSE TO CLOMIPRAMINE

被引:25
作者
HANNA, GL
MCCRACKEN, JT
CANTWELL, DP
机构
[1] Division of Mental Retardation and Child Psychiatry, Neuropsychiatric Institute, University of California at Los Angeles
关键词
OBSESSIVE-COMPULSIVE DISORDER; PROLACTIN; CLOMIPRAMINE; SEROTONIN; TICS;
D O I
10.1097/00004583-199103000-00002
中图分类号
B844 [发展心理学(人类心理学)];
学科分类号
040202 ;
摘要
Basal prolactin concentrations were measured before treatment in 18 children and adolescents with obsessive-compulsive disorder as well as in 15 of these patients after 4 and 8 weeks of clomipramine treatment. Basal prolactin levels were influenced by a history of chronic tic disorder and by the duration and severity of obsessive-compulsive symptoms. Clomipramine administration significantly increased basal prolactin levels. A slight decline in prolactin levels during the last 4 weeks of clomipramine treatment was positively correlated with a favorable treatment response and negatively correlated with duration of illness. If the changes in prolactin levels observed during clomipramine treatment are due primarily to changes in serotonergic neurotransmission, these data suggest that clomipramine treatment of obsessive-compulsive disorder produces an adaptive decrease in the responsiveness of serotonergic receptors.
引用
收藏
页码:173 / 178
页数:6
相关论文
共 47 条
[1]   SEROTONERGIC CONTROL OF PROLACTIN-RELEASE IN MALE RATS [J].
ADVIS, JP ;
SIMPKINS, JW ;
BENNETT, J ;
MEITES, J .
LIFE SCIENCES, 1979, 24 (04) :359-365
[2]  
American Psychiatric Association, 1987, DIAGNOSTIC STAT MANU, V3rd
[3]   DORSAL RAPHE-HYPOTHALAMIC PROJECTIONS PROVIDE THE STIMULATORY SEROTONERGIC INPUT TO SUCKLING-INDUCED PROLACTIN-RELEASE [J].
BAROFSKY, AL ;
TAYLOR, J ;
MASSARI, VJ .
ENDOCRINOLOGY, 1983, 113 (05) :1894-1903
[4]   NEUROENDOCRINE REGULATION OF PROLACTIN-RELEASE [J].
BENJONATHAN, N ;
ARBOGAST, LA ;
HYDE, JF .
PROGRESS IN NEUROBIOLOGY, 1989, 33 (5-6) :399-447
[5]  
BENKELFAT C, 1989, ARCH GEN PSYCHIAT, V46, P23
[6]   BIOGENIC-AMINE METABOLISM IN TOURETTE SYNDROME [J].
BUTLER, IJ ;
KOSLOW, SH ;
SEIFERT, WE ;
CAPRIOLI, RM ;
SINGER, HS .
ANNALS OF NEUROLOGY, 1979, 6 (01) :37-39
[7]  
CHARIG EM, 1986, HUM PSYCHOPHARM CLIN, V1, P93
[8]  
CHARNEY DS, 1988, ARCH GEN PSYCHIAT, V45, P177
[9]  
COHEN DJ, 1978, ARCH GEN PSYCHIAT, V35, P245
[10]  
COLE EN, 1976, POSTGRAD MED J, V52, P93